Table 2_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.xlsx od Han Qu (4391905)

Hasła przedmiotowe:

Table 1_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.docx od Han Qu (4391905)

Hasła przedmiotowe:

Table 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx od Satoko Watanabe (59124)

Hasła przedmiotowe:

Table 3_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx od Satoko Watanabe (59124)

Hasła przedmiotowe:

Table 4_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx od Satoko Watanabe (59124)

Hasła przedmiotowe:

Data Sheet 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.pdf od Satoko Watanabe (59124)

Hasła przedmiotowe:

Table 2_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx od Satoko Watanabe (59124)

Hasła przedmiotowe: